Compare Mutual Funds
Pros | - | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 6/11 | 10/11 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 5 Years | 14 Years | ||
Fund AUM | ₹266 Cr | ₹9166 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.92% | 1% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | Nifty Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 38 | 40 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 99.29% | 97.3% | ||
Debt % | - | - | ||
P/E | 43.22 | 37.98 | ||
P/B | 6.1 | 5.6 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 2.3% | 1.64% | ||
3-Month Return | 0.41% | -0.65% | ||
6-Month Return | 12.46% | 8.75% | ||
1-Year Return | 11.52% | 10.54% | ||
3-Year Return | 20.71% | 18.88% | ||
5-Year Return | - | 14.54% |
Sharpe | 0.85 | 0.83 | ||
Alpha | -0.47 | -2.19 | ||
Beta | 0.96 | 0.89 | ||
Standard Deviation | 16.51 | 14.87 | ||
Information Ratio | -0.26 | -1.14 |
Description | ITI Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Nilay Dalal, Animesh Singh | Sailesh Raj Bhan, Amber Singhania, Kinjal Desai |

